1. Home
  2. TNGX vs ONBPO Comparison

TNGX vs ONBPO Comparison

Compare TNGX & ONBPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • ONBPO
  • Stock Information
  • Founded
  • TNGX 2014
  • ONBPO N/A
  • Country
  • TNGX United States
  • ONBPO United States
  • Employees
  • TNGX N/A
  • ONBPO 4267
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • ONBPO Major Banks
  • Sector
  • TNGX Health Care
  • ONBPO Finance
  • Exchange
  • TNGX Nasdaq
  • ONBPO Nasdaq
  • Market Cap
  • TNGX 735.0M
  • ONBPO N/A
  • IPO Year
  • TNGX N/A
  • ONBPO N/A
  • Fundamental
  • Price
  • TNGX $6.64
  • ONBPO $25.32
  • Analyst Decision
  • TNGX Strong Buy
  • ONBPO
  • Analyst Count
  • TNGX 8
  • ONBPO 0
  • Target Price
  • TNGX $15.14
  • ONBPO N/A
  • AVG Volume (30 Days)
  • TNGX 885.7K
  • ONBPO N/A
  • Earning Date
  • TNGX 11-06-2024
  • ONBPO N/A
  • Dividend Yield
  • TNGX N/A
  • ONBPO N/A
  • EPS Growth
  • TNGX N/A
  • ONBPO N/A
  • EPS
  • TNGX N/A
  • ONBPO N/A
  • Revenue
  • TNGX $42,509,000.00
  • ONBPO N/A
  • Revenue This Year
  • TNGX $18.15
  • ONBPO N/A
  • Revenue Next Year
  • TNGX N/A
  • ONBPO N/A
  • P/E Ratio
  • TNGX N/A
  • ONBPO N/A
  • Revenue Growth
  • TNGX 26.16
  • ONBPO N/A
  • 52 Week Low
  • TNGX $6.33
  • ONBPO N/A
  • 52 Week High
  • TNGX $13.01
  • ONBPO N/A
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 37.15
  • ONBPO 46.88
  • Support Level
  • TNGX $6.83
  • ONBPO $25.21
  • Resistance Level
  • TNGX $7.47
  • ONBPO $25.70
  • Average True Range (ATR)
  • TNGX 0.37
  • ONBPO 0.18
  • MACD
  • TNGX 0.11
  • ONBPO -0.01
  • Stochastic Oscillator
  • TNGX 27.31
  • ONBPO 36.01

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About ONBPO Old National Bancorp Depositary Shares Each Representing a 1/40th Interest in a Share of Series C Preferred Stock

Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.

Share on Social Networks: